Lance Baldo, Chief Medical Officer at Adaptive Biotechnologies Corp (ADPT), sold 3,350 shares at $11.43 ($38K) on 2022-03-08, disclosed to the SEC on 2022-03-10.
Scheduled sale ($38k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ADPT | SELL | 2021-01-29 | $4.7M | — | Filing → |
| ADPT | SELL | 2020-12-09 | $442K | — | Filing → |
| ADPT | SELL | 2020-11-10 | $592K | — | Filing → |